切换至 "中华医学电子期刊资源库"

第五届中国出版政府奖音像电子网络出版物奖提名奖

中国科技核心期刊

中国科学引文数据库(CSCD)来源期刊

中华重症医学电子杂志 ›› 2022, Vol. 08 ›› Issue (03) : 230 -234. doi: 10.3877/cma.j.issn.2096-1537.2022.03.008

临床研究

纳布啡对心胸外科术后机械通气患者呼吸驱动的影响
李卿1, 于月1, 何远超1, 梁媚皓1, 陈辉1, 刘玲1,()   
  1. 1. 210009 南京,江苏省重症医学重点实验室 东南大学附属中大医院重症医学科
  • 收稿日期:2021-12-22 出版日期:2022-08-28
  • 通信作者: 刘玲
  • 基金资助:
    国家自然科学基金项目(81870066); 江苏省科技厅重点研发(社发)项目(BE2020786); 江苏省医学青年人才项目(QNRC2016807); 江苏省第六期“333高层次人才培养工程”项目

Effects of Nalbuphine on respiratory drive in post-cardiothoracic surgery patients received mechanical ventilation

Qing Li1, Yue Yu1, Yuanchao He1, Meihao Liang1, Hui Chen1, Ling Liu1,()   

  1. 1. Department of Critical Care Medicine, Jiangsu Provincial Key Laboratory of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing 210009, China
  • Received:2021-12-22 Published:2022-08-28
  • Corresponding author: Ling Liu
引用本文:

李卿, 于月, 何远超, 梁媚皓, 陈辉, 刘玲. 纳布啡对心胸外科术后机械通气患者呼吸驱动的影响[J/OL]. 中华重症医学电子杂志, 2022, 08(03): 230-234.

Qing Li, Yue Yu, Yuanchao He, Meihao Liang, Hui Chen, Ling Liu. Effects of Nalbuphine on respiratory drive in post-cardiothoracic surgery patients received mechanical ventilation[J/OL]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2022, 08(03): 230-234.

目的

探讨纳布啡持续输注对心胸外科术后机械通气患者呼吸中枢驱动的影响。

方法

纳入2019年3月至12月因心胸外科术后入住东南大学附属中大医院ICU需要镇痛的机械通气患者26例,其中男性17例,年龄59(49,69)岁,急性生理学与慢性健康状况(APACHE Ⅱ)评分为(9.5±4.5)分,序贯器官衰竭评估(SOFA)评分为(3.1±2.5)分。患者采用压力支持通气(PSV),给予2个剂量的纳布啡持续静脉泵入镇痛,维持重症监护疼痛观察工具(CPOT)评分在0分。在纳布啡镇痛治疗前(T0)、纳布啡镇痛达到CPOT评分0分后1 h(T1)、纳布啡剂量增加50%后1 h(T2)及纳布啡恢复初始剂量后1 h(T3)等时间点,通过膈肌电活动(EAdi)及气道阻断压(P0.1)反映呼吸驱动,记录患者生命体征、血气分析等指标,并通过COPT及Richmond躁动-镇静评分(RASS)评估纳布啡的疗效。

结果

与T0时比较,纳布啡持续输注剂量为0.10 mg/(kg·h)及0.15 mg/(kg·h)时患者CPOT及RASS评分均明显降低,所有患者均达到临床需求的镇痛/镇静效果。患者T0时的EAdi为6.0(4.5,8.0)μV,镇痛后T1时为6.4(3.6,7.4)μV,T2时为5.3(3.6,6.0)μV,T3时为6.1(4.6,7.2)μV,与T0相比,T1、T2、T3时的EAdi差异均无统计学意义(P>0.05)。患者T0时的P0.1为2.0(1.1,2.9)cmH2O,镇痛后T1时为2.0(0.9,3.2)cmH2O,T2时为2.0(1.1,3.4)cmH2O,T3时为2.2(1.2,3.6)cmH2O,与T0相比,T1、T2、T3时的P0.1差异均无统计学意义(P>0.05)。各时间点之间患者的心率、血压、血气指标及膈肌活动度、膈肌增厚分数、神经通气效能、神经机械效能比较,差异均无统计学意义(P>0.05)。

结论

对于心胸外科术后需要机械通气的患者,纳布啡持续输注可实现有效镇痛,增加剂量不抑制患者呼吸驱动,且对生命体征及膈肌功能无明显影响。

Objective

To evaluate the physiological effects of continuous Nalbuphine infusion on respiratory drive in post-cardiothoracic surgery patients received mechanical ventilation.

Methods

This was a prospective study which enrolled 26 post-cardiothoracic surgery patients received mechanical ventilation admitted to intensive care unit (ICU), Zhongda Hospital from March to December 2019. There were 17 men, aged 59 (49, 69), with acute physiology and chronic health (APACHE Ⅱ) score of (9.5±4.5) and sequential organ failure assessment (SOFA) score of (3.1±2.5). All included patients received mechanical ventilation with PSV mode and continuous Nalbuphine infusion at two dosages. Vital signs and blood gas analysis were recorded before intervention (T0); 1 hour after infusion of nalbuphine with CPOT score of zero (T1); 1 hour after the dose of Nalbuphine was increased by 50% (T2); and 1 hour after the dose of Nalbuphine was adjusted as at T1 (T3). Respiratory drive was evaluated by diaphragm electrical activity (EAdi) and P0.1; the effects of Nalbuphine was evaluated by CPOT and RASS score.

Results

Compared with T0, the CPOT and RASS scores were significantly decreased at 0.10 mg / (kg·h) and 0.15 mg / (kg·h), and patients all achieved satisfactory analgesia / sedation. EAdi at T0 was 6.0 (4.5, 8.0) μV, 6.4 (3.6, 7.4) μV at T1, 5.3 (3.6, 6.0) μV at T2, and 6.1 (4.6, 7.2) μV at T3, showing no significant differences in EAdi at T1, T2 or T3 compared with T0 (P>0.05). P0.1 at T0 was 2.0 (1.1, 2.9) cmH2O, 2.0 (0.9, 3.2) cmH2O at T1, 2.0 (1.1, 3.4) cmH2O at T2, and 2.2 (1.2, 3.6) cmH2O at T3, showing no significant difference in P0.1 at T1, T2 or T3 compared with T0 (P>0.05). Meanwhile, there were no significant differences in HR, blood pressure, blood gas index, diaphragm activity, diaphragm thickening fraction (DTF), neuro-ventilator efficiency (NVE), neuro-muscular efficiency (NME) between groups (P>0.05).

Conclusion

Nalbuphine has a satisfactory analgesic effect on post-cardiothoracic surgery patients received mechanical ventilation without obvious effects on respiratory drive, vital sign and diaphragmatic function with increasing the dose.

表1 纳布啡对不同时间点机械通气患者镇痛镇静评分、生命体征、血气分析及膈肌功能的影响(
xˉ
±s
图1 纳布啡镇痛对呼吸驱动的影响。图a为不同时间点EAdi;图b为不同时间点P0.1注:T0为纳布啡镇痛前;T1为纳布啡镇痛达到CPOT评分为0后1 h;T2为纳布啡剂量增加50%后1 h;T3为纳布啡恢复初始剂量后1 h;EAdi为膈肌电活动;P0.1为气道阻断压
1
Vanderah TW. Delta and Kappa opioid receptors as suitable drug targets for pain [J]. Clin J Pain, 2010, 26(Suppl 10): S10-S15.
2
Beaver WT, Feise GA. A comparison of the analgesic effects of intramuscular nalbuphine and morphine in patients with postoper-ative pain [J]. J Pharmacol Exp Ther, 1978, 204(2): 487-496.
3
Akshat S, Ranlachandran R, Rewari V, et al. Morphine versus nalbuphine for open gynaecological surgery: a randomized con- trolled double blinded trial [J]. Pain Res Treat, 2014, 2014: 727952.
4
Prabhakaraiah UN, Narayanappa AB, Gurulingaswamy S, et al. Comparison of nalbuphine hydrochloride and fentanyl as an adjuvant to bupivacaine for spinal anesthesia in lower abdominal surgeries: a randomized, double-blind study [J]. Anesth Essays Res, 2017, 11(4): 859-863.
5
贾丽, 张静, 邢玉英, 等. 纳布啡复合丙泊酚用于人工流产术的改良效果 [J]. 中华麻醉学杂志, 2020, 40(2): 210-212.
6
Ling L, Huogen L, Yi Y, et al. Neuroventilatory efficiency and extubation rEAdiness in critically ill patients [J]. Crit Care, 2012, 16: R143.
7
刘韶华, 万有栋, 罗永刚, 等. 纳布啡用于ICU患者镇痛的有效性和安全性 [J].中华危重病急救医学, 2018, 30(5): 471-476.
8
Devlin JW, Skrobik Y, Gélinas C, et al. clinical practice guidelines for the prevention and management of pain, agitation/sedation, delirium, immobility, and sleep disruption in adult patients in the ICU [J]. Crit Care Med, 2018, 46(9): e825-e873.
9
Culebras X, Gaggero G, Zatloukal J, et al. Advantages of intrathecal nalbuphine, compared with intrathecal morphine, after cesarean delivery: an evaluation of postoperative analgesia and adverse effects [J]. Anesth Analg, 2000, 91(3): 601-605.
10
Singh H, Yang J, Thornton K, et al. Intrathecal fentanyl prolongs sensory bupivacaine spinal block [J]. Can J Anaesth, 1995, 42(11): 987-991.
11
Hannhart B, Boulanger G, Audibert G, et al. Nalbuphine analgesia preserves ventilation after thoracotomy despite a reduction in inspiratory drive [J]. Respiration, 1992, 59(3): 159-163.
[1] 薛翔, 陈娇, 贾凌, 杨敬辉, 蔡建芹, 陈昆仑, 赵炜. 肺内叩击通气在上腹部术后机械通气患者中的疗效分析[J/OL]. 中华危重症医学杂志(电子版), 2023, 16(06): 469-474.
[2] 豆艺璇, 黄怀, 钱绮雯, 邢然然, 林丽, 白建芳. 低强度吸气肌训练对机械通气患者肺康复的影响[J/OL]. 中华危重症医学杂志(电子版), 2023, 16(05): 370-375.
[3] 徐娟, 孙汝贤, 赵东亚, 张清艳, 金兆辰, 蔡燕. 右美托咪定序贯镇静模式对中深度镇静的机械通气患者预后和谵妄的影响[J/OL]. 中华危重症医学杂志(电子版), 2023, 16(05): 363-369.
[4] 张璇, 高杨, 房雅君, 姚艳玲. 保护性机械通气在肺癌胸腔镜肺段切除术中的临床应用[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(04): 563-567.
[5] 彭祺, 马丽娜, 李倩倩, 陈旭. 重症病毒性肺炎机械通气脱机的影响因素分析[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(02): 260-263.
[6] 叶观生, 黄潘文, 莫伟良, 钟许昌. 序贯NCPAP、HHFNC对肺炎并发呼吸衰竭氧合指数的影响[J/OL]. 中华肺部疾病杂志(电子版), 2024, 17(01): 99-102.
[7] 潘清, 葛慧青. 基于机械通气波形大数据的人机不同步自动监测方法[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 399-403.
[8] 韦小霞, 陈管洁, 李雪珠, 李晓青, 钱淑媛. 机械通气患者抗菌药物雾化吸入的临床实施[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 334-337.
[9] 苗明月, 周建新. 肺保护性镇静:应重视呼吸驱动和吸气努力的床旁评估[J/OL]. 中华重症医学电子杂志, 2024, 10(04): 325-328.
[10] 倪韫晖, 杨毅, 袁雪燕, 邱海波. 胸壁加压在急性呼吸窘迫综合征中的应用和临床进展[J/OL]. 中华重症医学电子杂志, 2024, 10(03): 243-247.
[11] 刘春峰, 徐朝晖, 施红伟, 陈瑢, 马腾飞, 李鹏飞, 袁蓉, 陈建荣, 徐爱明. 机械通气患者肌肉减少症的诊断及其对预后的影响[J/OL]. 中华临床医师杂志(电子版), 2024, 18(09): 820-825.
[12] 王文珠, 刘建, 袁常秀, 石亚飞, 尤培军. 竖脊肌平面阻滞对非体外循环冠状动脉旁路移植术中阿片类药物用量的影响[J/OL]. 中华诊断学电子杂志, 2024, 12(03): 155-159.
[13] 李春光, 杨洋, 李斌, 华荣, 孙益峰, 李志刚. 不同外科修复模式治疗机械通气相关气管食管瘘的短期疗效评价[J/OL]. 中华胸部外科电子杂志, 2024, 11(03): 151-157.
[14] 刘晴雯, 韩勇, 陈丽丹, 邓哲. 早期机械通气对成人院内心脏骤停病死率的影响:一项回顾性队列研究[J/OL]. 中华卫生应急电子杂志, 2024, 10(04): 203-206.
[15] 刘晓鹏, 柳聪艳, 杨宁, 蔡琛, 李晓兵, 王红宇, 张思森. 三穴五针联合腹部提压法在机械通气患者肺康复中的疗效[J/OL]. 中华卫生应急电子杂志, 2024, 10(04): 193-198.
阅读次数
全文


摘要